Ethosuximide, a T-type calcium channel blocker, demonstrated no significant benefit as a treatment for patients with ...

Researchers at Scripps Research have redesigned fentanyl at the molecular level, challenging decades-old assumptions about opioid chemistry.

Repurposing a Food and Drug Administration (FDA)-approved drug for a new use has been informally practiced for years. In fact, “off-label” medication administration is so common that the Congressional ...

Clinical trials of a novel non-opioid analgesic have found it to be effective in reducing acute postoperative pain, opening the door to a new way of managing short-term pain that avoids the pitfalls ...